Human studies link fine particulate matter with higher dementia with Lewy bodies risk; a memory-clinic cohort also links probable REM sleep behavior disorder with higher risk. In people with mild cognitive impairment, a study links resting tremor, masked facies and bradykinesia with higher risk. Smoking associations point in opposite directions across human studies.
99 findings in 63 papers from 2019 to 2026, 17 of them since May 2026
GLP-1 receptor agonists were not clearly linked with dementia with Lewy bodies in humans (REM sleep behavior disorder and type 2 diabetes; compared with DPP-4 inhibitor use) (HR 0.45, 95% CI 0.04–5.37; not statistically significant).
“but not DLB (HR, 0.45; 95% CI, 0.04–5.37)”
HumansREM sleep behavior disorder and type 2 diabetes; compared with DPP-4 inhibitor usen = 148
GLP-1 receptor agonists were not clearly linked with dementia with Lewy bodies in humans (compared with DPP-4i new users; iRBD and type 2 diabetes) (HR 0.45; 95% CI 0.04–5.37).
“but not LBD (HR, 0.45; 95% CI, 0.04 - 5.37)”
Humanscompared with DPP-4i new users; iRBD and type 2 diabetesn = 148
SGLT2 inhibitors were not clearly linked with dementia with Lewy bodies in humans (REM sleep behavior disorder and type 2 diabetes; compared with DPP-4 inhibitor use) (HR 0.94, 95% CI 0.17–5.17; not statistically significant).
“but not DLB (HR, 0.94; 95% CI, 0.17–5.17)”
HumansREM sleep behavior disorder and type 2 diabetes; compared with DPP-4 inhibitor usen = 138
Dementia with Lewy bodies were not clearly linked with proactive balance adjustments in humans (Compared with age- and BMI-matched controls during treadmill-induced perturbations).
“we found that the DLB group did not exhibit worse proactive adjustments than controls”
HumansCompared with age- and BMI-matched controls during treadmill-induced perturbations
Abnormal perceptual experiences and hallucinations
↑upin humans1
1 study
Dementia with Lewy bodies are linked with higher abnormal perceptual experiences and hallucinations in humans (comparison with PD) (Cohen's d = 3.02).
“DLB participants exhibited higher mean MUSEQ scores (Cohen's d = 3.02) and more illusory responses on the Noise Pareidolia Test than PD (Cohen's d = 1.63).”
Smoking is linked with a higher risk of dementia with Lewy bodies in humans (overall cohort).
“In the overall cohort, smoking, not living in a suburb, exposure to glue/adhesive at work, welding/brazing/flame cutting metal, soldering, and metal dust/dust fumes in adulthood were significantly associated with LBD risk.”
PC lowers the risk of dementia with Lewy bodies in silico (OR=0.86, 95% CI=0.75-0.98).
“phosphatidylcholine (PC) (O-16:0_20:4) levels (OR=0.86, 95% CI=0.75-0.98, P=0.02) and PC (O-18:1_20:4) levels (OR=0.76, 95% CI=0.65-0.89, P <0.001) had negative causal effects on LBD”
Sleep duration is associated with dementia with Lewy bodies in humans (sleeping <5 h) (adjusted OR = 1.795, 95%CI: 1.055-3.054, p < 0.05).
“Sleeping for <5 h (adjusted OR = 1.795, 95%CI: 1.055-3.054, p < 0.05) or having hypersomnolence (adjusted OR = 31.213, 95% CI: 17.618-55.301, p < 0.001) were significantly associated with the occurrence of DLB.”
Dementia with Lewy bodies is linked with frailty, probable sarcopenia and worse physical function in human studies. People with the disease have weaker grip and more falls than those with Alzheimer's disease. In people with mild cognitive impairment, resting tremor, masked facies and bradykinesia are linked with later Lewy body dementia.
A human study links dementia with Lewy bodies to reactive balance response magnitude, but not proactive adjustments. A PET–MRI network predicts it in patients with isolated REM sleep behavior disorder, while a Mendelian randomization study links statins to increased risk.
Glucagon-like peptide-1 receptor agonists were linked to lower Parkinson’s risk than dipeptidyl peptidase-4 inhibitors, with a hazard ratio, measuring relative risk, of…Glucagon-like peptide-1 receptor agonists were linked to lower Parkinson’s risk than dipeptidyl peptidase-4 inhibitors, with a hazard ratio, measuring relative risk, of 0.02.
Movement scores worsened by 0.611 points a year in test-positive participants versus 0.139 in test-negative participants followed for up to 12 years.Movement scores worsened by 0.611 points a year in test-positive participants versus 0.139 in test-negative participants followed for up to 12 years.
Compared with unexposed veterans, those reporting exposure had a higher relative risk of Parkinson disease diagnosis, with a hazard ratio of 1.44.Compared with unexposed veterans, those reporting exposure had a higher relative risk of Parkinson disease diagnosis, with a hazard ratio of 1.44.